Crossref
VHL Suppresses Malignant Phenotypes in Melanoma and Is Associated with TGF-β/SMAD3 Signaling
Oncology Research · 2026 · 1-10
DOI: 10.32604/or.2026.091665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Jiajia Qian und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Qian, J., Wang, K., Ruan, C., Hu, W., Wang, Q., Ye, L., Chen, Y., & Xu, R. (2026). VHL Suppresses Malignant Phenotypes in Melanoma and Is Associated with TGF-β/SMAD3 Signaling. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.091665
Vancouver
Qian J, Wang K, Ruan C, Hu W, Wang Q, Ye L, et al. VHL Suppresses Malignant Phenotypes in Melanoma and Is Associated with TGF-β/SMAD3 Signaling. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.091665
BibTeX
@article{Qian2026,
author = {Qian, Jiajia and Wang, Kangwei and Ruan, Cong and Hu, Weiqiong and Wang, Qiru and Ye, Ling and Chen, Yong and Xu, Rui},
title = {VHL Suppresses Malignant Phenotypes in Melanoma and Is Associated with TGF-β/SMAD3 Signaling},
journal = {Oncology Research},
year = {2026},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/or.2026.091665}
}
EUVIMED